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Five patients seen during a two-month period who developed untoward systemic reactions following high
dose intravenous administration of nafcillin are described. Recovery was complete upon discontinuation of
the drug. The clustering ofthese cases and the high incidence (5 of 5) of side effects are highly unusual, and
suggest that the frequency of nafcillin reactions might be higher than previously suspected.
It is assumed that all penicillinase-resistant semi-synthetic penicillins are equally
effective in treating infections caused by Staphylococcus aureus [1,2]. Little is known,
however, about the relative toxicities of these antibiotics. Of the major side effects,
rash, urticaria, fever, allergic interstitial nephritis, hepatic toxicity, and hematologic
toxicity in the form ofreversible granulocytopenia have been commented upon in the
literature [3-10].
Nafcillin, 6-(2-ethoxy-l-naphthalmido) penicillanic acid, has been preferred by
some clinicians over methicillin and oxacillin, because its use may be associated with
a lower incidence of side effects, particularly nephropathy [11]. Furthermore, in one
study nafcillin offered better synergistic activity than other penicillinase-resistant
penicillins with an aminoglycoside when tested against the enterococci [12].
This report describes an unusually high occurrence of untoward reactions due to
nafcillin observed by us at Yale-New Haven Hospital. During the months ofJuly and
August of 1976, five patients, four of whom were seen and followed by the Infectious
Disease Section, received high dose intravenous nafcillin for proven or presumed
staphylococcal infections. All five subsequently developed various drug reactions,
necessitating discontinuation of nafcillin in four of the patients. To the best of our
knowledge, no other patient received nafcillin at our institution during this period.
CASE REPORTS
Case I
A 22-year-old male with chronic non-union ofa left tibial fracture underwent open
reduction with internal fixation and bone grafting ofthe left tibia at Yale-New Haven
Hospital. Twenty-five days later he was re-admitted to the hospital with a 3-day
history offever, rigors, and local pain and swelling at the site ofoperation. There was
no history of trauma, or allergies. On admission to the hospital the patient had a
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temperature of 101.60 F, a pulse of 108/min, respirations of 18/min, and a BP of
130/80 mm Hg. On physical exam the surgical wound of the left leg was erythema-
tous, swollen, and tender. Tender left inguinal adenopathy was also noted. The
remainder of the exam was negative. Admission. laboratory findings revealed an
erythrocyte sedimentation rate of 57 mm/hr, a hemoglobin of 11.5 g/dl, and a
hematocrit of 34.7%. The WBC count was 10,300/mm3, with 72% segmented
neutrophils, 6% bands, 17% lymphocytes, and 6% monocytes. Urinalysis, BUN,
creatinin, electrolytes, and the results of the liver function studies were normal.
Cultures of the wound aspirate as well as cultures obtained during surgical debride-
ment yielded S. aureus. Intravenous oxacillin in the dosage of 1 g every 6 hours was
begun, and two days later was changed to intravenous nafcillin 2 g, every 6 hours.
The wound infection responded satisfactorily to treatment, and the temperature
returned to normal. On the twentieth day of nafcillin therapy, the WBC count was
4,300/mm3, with 38% neutrophils, 21% bands, 25% lymphocytes, 5% monocytes, and
7% eosinophils. On the twenty-first day of nafcillin therapy, he developed a fever of
1020 F, and by the twenty-second day a confluent, erythematous, maculopapular
rash appeared with a fever of 1030 F. The WBC count was 935/mm3, with 5%
segmented neutrophils, 2% bands, 57% lymphocytes, 29% monocytes, and 6%
eosinophils. Nafcillin was discontinued and during the following five days the WBC
count rose to 6,100/mm3, with 34% neutrophils, 10% bands, 26% lymphocytes, 10%
monocytes, and 16% eosinophils. The fever and rash also disappeared. The results of
urinalysis, renal, and liver function studies remained normal. The patient received
several other medications at the time of his reaction, none of which were stopped
while he recovered successfully. Two weeks after cessation of nafcillin, at the time of
discharge, the patient was asymptomatic, and had a WBC count of9,500/mm3, with
59% neutrophil, 2% bands, 29% lymphocytes, 8% monocytes, and 2% eosinophils.
Case 2
A 22-year-old male was seen at Yale-New Haven Hospital Emergency Room with
a 10-day history of right tibial pain and swelling, and 3 days of fever, and night
sweats. There was no history of trauma or allergies. Physical exam revealed a
temperature of 99.20 F orally, a pulse of 72/min, respirations 18/min, and a BP of
130/80 mm Hg. Edema, increased warmth, tenderness along the mid-shaft of the
right tibia, and a positive Homan's sign were noted. The remainder of exam was
negative. The erythrocyte sedimentation rate was 38 mm/hr, the hemoglobin 14 g/dl,
and the hematocrit 40.5%. The WBC count was 9,600/mm3, with 72% segmented
neutrophils, 15% bands, 7% lymphocytes, and 6% monocytes. Films oftheright tibia
and a venographic study of the right leg were negative. Two days later a 99Tc-bone
scan showed diffuse increased uptake of the right tibia, and the patient was admitted
to the hospital. Surgical exploration of the right tibia revealed a "roughened"
periosteum, and necrotic bone; however, no gross pus or tumor was noted. The
surgical biopsy did not show definite evidence of infection or tumor. All of the
operative cultures were negative except for one specimen from the medullary cavity
which yielded a few Staph. epidermidis. It was felt that the patient's presentation was
most compatible with osteomyelitis, and therapy with intravenous cephalothin at a
dosage of 1 g every 4 hours was begun postoperatively. This was changed three days
later to intravenous nafcillin, 2 g every 6 hours. On the thirteenth day of nafcillin
therapy the WBC count was 7,000/mm3, with 66% neutrophils, 5% bands, 10%
lymphocytes, 10% monocytes, and ¶,% eosinophils. On the seventeenth day of
nafcillin therapy, the patient developed a pruritic, maculopapular rash on the trunk
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and shoulders. The WBC count was 3,700/mm3, with 30% segmented neutrophils,
10% bands, 38% lymphocytes, 11% monocytes, and 11% eosinophils. Urinalysis,
renal, and liver function tests were normal. Nafcillin was stopped on the seventeenth
day oftherapy, and intravenous cephalothin, 1 g every 4 hours was started. No other
medications were stopped. During the following three days the WBC count rose to
5,100/mm3, with 65% neutrophils, 3% bands, 20% lymphocytes, 10% monocytes, and
2% eosinophils. The rash improved within one week. Several months after discharge
the patient was asymptomatic, and had a normal erythrocyte sedimentation rate and
radiographic evidence of healing of the right tibia.
Case 3
A 53-year-old man underwent exploration of the right knee with removal of the
torn medial meniscus at Yale-New Haven Hospital. He was discharged 2 days after
the operation. Three days later he fell, and sustained a flexion injury to the right
knee, causing dehiscence of the inferior pole of the surgical wound, and a small
amount of drainage. The next day he was seen in the Orthopedic Clinic, where the
wound was aspirated, and phenoxymethyl penicillin, 250 mg, four times a day was
started. During the subsequent weeic, pain and swelling of the right knee became
worse, and after a culture of the wound yielded S. aureus. resistant to penicillin, the
patient was admitted to the hospital. On admission he had a temperature of98.80 F
orally, a pulse of90/min, respirations 14/min, and a BP of 120/80 mm Hg. Physical
exam revealed a partially open right knee wound, with swelling, tenderness, and
surrounding erythema. The remainder ofthe exam was negative. Admission labora-
tory showed a hemoglobin of 15.1 g/dl, a hematrocrit of44.1%, and a WBC count of
8,500/mm3, with 67% neutrophils, 3% bands, 20% lymphocytes, 8% monocytes, 1%
basophils, and 1% eosinophils. An X-ray film of the knee showed only soft tissue
swelling. Urinalysis, electrolytes, BUN, creatinin and the liver function studies were
normal. Gram stain and culture of the wound revealed S. aureus. Treatment with
intravenous nafcillin, at the dosage of 2 g every 6 hours, was started, with rapid
improvement of the wound infection. On the eighth day of nafcillin therapy the
patient developed a fever of 103° F, and a WBC count of 7,800/mm3, with 60%
neutrophils, 7% bands, 11% lymphocytes, 12% monocytes, and 8% eosinophils. Fever
persisted and on the twelfth day of nafcillin therapy a pruritic, erythematous,
maculopapular rash developed on the extremities and chest, which soon became
generalized. The WBC count was unchanged, and the results of urinalysis, renal and
hepatic function tests remained normal. Nafcillin was stopped, but all of his other
medications were continued. Because of persistence of severe, symptomatic rash,
unresponsive to diphenhydramine, treatment with hydrocortisone 100 mg intrave-
nously, followed by 30 mg of prednisone/day, for two days was given with rapid
improvement of the rash and return of the temperature to normal. Three days later,
cephalexin 500 mg, then subsequently 1 g, four times/day was begun. During the
following week the wound improved considerably and the patient remained asympto-
matic. He was discharged on cephalexin 4 g/day.
Case 4
A 19-year-old male was admitted to another hospital with a 3-month history of
progressive low back pain, and the recent onset ofnight sweats. There was no history
of trauma, allergy, or neurologic deficits. Physical exam showed marked paraverte-
bral muscle spasm, local tenderness ofthe lower lumbar spine, and severe limitation
451ZAKHIREH AND ROOT
of spine movements. Tomographic examination of the lumbar spine was compatible
with osteomyelitis of the L3 vertebra, with destruction of the L3--4 disc space. The
patient was subsequently transferred to Yale-New Haven Hospital. Physical exam
was unchanged. The admission laboratory data showed an erythrocyte sedimentation
rate of 47 mm/hr, a hemoglobin of 13.1 g/dl, a hematocrit of 39.8%, and a WBC
count of 11,000/mm3, with 76% segmented neutrophils, 2% bands, 14% lymphocytes,
6% monocytes, and 1% eosinophils. The remainder of laboratory exams were.within
normal limits. Surgical exploration confirmed the diagnosis of osteomyelitis. All of
the bone cultures and one blood culture yielded S. aureus. Post operatively, therapy
with intravenous nafcillin, 2 g every 6 hours, was started. On the eighth day of
nafcillin therapy a pruritic, maculopapular rash appeared onthe abdomen and chest,
and rapidly involved the extremities. The WBC count was 12,800/mm3, with 74%
neutrophils, 13% lymphocytes, 6% monocytes, and 7% eosinophils. All other
laboratory results, including the urinalysis, BUN, and liver function tests were
normal. Nafcillin was stopped, and the rash and eosinophilia improved during the
subsequent 3 days. None of the patient's other medications were stopped. Therapy
with intravenous cephalothin, 2 g every 6 hours was then started, and continued for a
total of 30 days. At the time of discharge, the erythrocyte sedimentation was normal,
and the WBC count was 8,600/mm3, with 70% neutrophils, 5% bands, 16%
lymphocytes, 6% monocytes, 2% basophils, and 1% eosinophils.
Case 5
A 60-year-old male was admitted to Yale-New Haven Hospital after he fell and
sustained a fracture of the mid-shaft of the left femur. On admission, physical exam
was negative, except for a BP of 152/94 mm Hg, and the pertinent findings associated
with the femoral fracture. The admission laboratory data revealed a hemoglobin of
14.6 g/dl, a hematocrit of 43.3%, and a WBC count of 8,800/mm3, with 71%
neutrophils, 4% bands, 19% lymphocytes and 6% monocytes. Hydrochlorathiazide,
25 mg/day, was given for hypertension, but stopped after 2 weeks. Treatment with
traction was employed initially, and 3 weeks after the admission he underwent
internal fixation ofthe left femur with placement of a Kuntschner rod. Perioperative
cephalothin, 1 g every 4 hours, was given for a total of 10 doses. On the twelfth
postoperative day the patient developed fever of 1020F, and evidence of the surgical
wound infection. Wound cultures yielded an abundant growth of S. aureus. Treat-
ment with intravenous cephalothin was restarted. After two days this was changed to
oxacillin and subsequently to intravenous nafcillin, at a dosage of 2 g every 6 hours.
In addition, surgical debridement of the wound was carried on. He responded well to
the treatment, with gradual clearing of the wound infection. However, CBC's on the
thirteenth to sixteenth day of nafcillin therapy showed a persistent eosinophilia of
11%. There was no rash, fever, renal or hepatic abnormalities. Nafcillin was stopped
after 21 days of therapy, and the patient was discharged on oral dicoloxacillin 500
mg, four times/day. The only other medications that the patient had received within
one week of development of the eosinophilia were meperidin, flurazepam, and
hydroxyzine. No further follow-up blood counts were available at the time of
preparation of this manuscript.
DISCUSSION
Adverse reactions to nafcillin have been infrequently reported in the past. Bone
marrow examination in two previous case studies ofnafcillin-induced granulocytope-
nia demonstrated a maturation arrest of the myeloid series at the myelocyte stage,
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without depression of the erythroid or the megkaryocytic series [9,10]. Nafcillin has
also been reported to cause interstitial nephritis in a patient with a previous history of
methicillin-induced nephropathy [8]. In a recent study comparing nafcillin and
methicillin in treatment of patients with serious staphylococcal infections, nafacillin
was associated with a substantially lower incidence of side effects. In particular, no
instances of nephropathy were observed in the 29 patients treated with nafcillin, and
only four patients developed reactions to the drug. One patient had only fever and
rash, two developed granulocytopenia, and one patient treated with the highest daily
dose of nafcillin (12 grams) developed granulocytopenia associated with fever and
rash [11]. In contrast, in another as yet not completed study comparing nafcillin
versus combination of nafcillin and gentamicin in treatment of severe staphylococcal
infections, reaction rates (eosinophilia, rash, and neutropenia) of over 50% have been
observed with combined regimen. Nafcillin alone has been associated with adverse
reactions in nearly 30% of cases (Merle Sande, M.D., personal communication). In
our series of five patients receiving intravenous nafcillin, all five developed untoward
reactions. Eosinophilia was seen in all, and maculopapular rash in four patients. Two
had both fever and a reversible granulocytopenia. No evidence of nephropathy or
liver damage was observed in any of the patients (Refer to Table 1.) All of the four
patients who had adequate follow-up experienced complete recovery upon discontin-
uation of nafcillin, and did not exhibit cross-reactive side effects with cephalosporins
as the substitute therapy. None of our patients had a past history ofallergic reactions
to the penicillins or other drugs. The nafcillin used during this period came from
different lots, was freshly prepared, and administered by the standard "piggy back"
intravenous infusion in isotonic saline, or 5% dextrose solution. Thus the possibility
that the reactions were due to the contamination of a single lot ofthe drug is unlikely.
Furthrermore the concurrent use of other medications in these patients was minimal,
and none were stopped when the adverse reactions appeared.
Fever, rash, and pruritus occurring on penicillin therapy have been attributed to
hypersensitivity reactions. Likewise, the interstitial nephritis due to penicillin and its
homologues (including nafcillin) is thought to represent a dose-related hypersensitiv-
ity reaction [8,13]. One group of investigators demonstrated antitubular basement
membrane antibodies in methicillin-associated nephritis [14]. The mechanism of
selective granulocytopenia by penicillin homologues has been the source of consider-
able speculation. Most patients, as did ours, appear to develop this complication at
about 3 weeks into treatment by these agents [7,9-11]. Both a direct toxic effect on
the granulocytic series [15], and an antibody-mediated hypersensitivity reaction [7,9]
have been suggested. In a recent study [16] antineutrophil antibodies were demon-
strated in the sera of 2 patients with nafcillin, and one patient with oxacillin-induced
granulocytopenia. The authors suggested that these drugs attach to the cell surface
where they function as haptens, with subsequent antibody attachment. The opson-
ized neutrophils are then sequestered and phagocytized by macrophages of the
reticuloendothelial organs. The association of eosinophilia and rash observed in our
patients with granulocytopenia favors a hypersensitivity reaction. However, further
studies are needed to elucidate the mechanism(s) of granulocytopenia due to
penicillin homologues.
These cases are brought to the attention of readers to emphasize the possibility that
when larger series of patients are treated with nafcillin, reaction rates will approach
those reported with other semi-synthetic, penicillinase-resistant penicillins. Careful
observation of patients receiving large doses of intravenous nafcillin (or other
penicillinase-resistant penicillins) for the development of hypersensitivity reactions,
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and frequent monitoring of blood counts with differentials, as well as renal and
hepatic functions are recommended, particularly after 2 weeks of treatment. If
isolated neutropenia (neutrophil count < 1,800/mm3) appears without other mani-
festations of hypersensitivity then the dose should be lowered and the patient
followed closely for other complications. Should these appear at any time or the
granulocyte count fall below 1,000/mm3 the drug should be stopped. Vancomycin or
a cephalosporin may provide suitable alternative treatment for staphylococcal
infections should such side effects be observed.
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